Similar to the in vivo results from the human NEPC cell line LASCPC-01, the xenograft tumor growth of the human SCLC cell line NCI-H146 was strongly inhibited by the ADORA2A inhibitor SCH (Figure 9, K and L). This evidence concerns the gene ADORA2A and neoplasm.